ERBB2 and esophageal cancer: Two cholesteryl pullulan‐based cancer vaccines, CHP‐NY‐ESO‐1 and CHP‐HER2, aroused antigen‐specific immune response against NY‐ESO‐1 and HER2 at the presence of OK‐432 adjuvant in esophageal cancer patients (NCT00291473).76